Osteokare

Antibotics

TAZOCEF 0.2812
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
250 mg

Tazobactam
31.25 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 0.2812 is available as a strip of 10 tablets
TAZOCEF 0.5625
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
500 mg

Tazobactam
62.5 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 0.5625 is available as a strip of 10 tablets
TAZOCEF 1.125
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
1000 mg

Tazobactam
125 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 1.125 is available as a strip of 10 tablets